Get started
Author

Alex M. L. Wu

Observed name: Alex Wu
Institution: Zymeworks (Canada)
Observed institution: Zymeworks (Canada)
ORCID: 0009-0001-6727-2604
Observed ORCID: 0009-0001-6727-2604
OpenAlex ID: A5047855355
Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al. · Molecular Cancer Therapeutics · 30
PDF
Supplementary Table S2 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2026 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Table S3 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2026 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Figure S4 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2026 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Figure S1 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2026 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Table S1 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2026 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Figure S2 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2026 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Figure S3 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2026 · Mark E. Petersen, Michael G. Brant, et al.
Abstract 1686: Development of ZW418, a biparatopic PTK7-targeting antibody-drug conjugate incorporating a novel pan-RAS inhibitor payload for the treatment of non-small cell lung cancer
2026 · Luying Yang, Alex Wu, et al. · Cancer Research
Supplementary Table S2 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Figure S2 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Figure S3 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Table S1 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Table S3 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al.
Synthetic Procedures from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Figure S4 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Table S1 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al.
Characterization of ADCs from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al.
Data from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Figure S1 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al.
Supplementary Figure S2 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · Mark E. Petersen, Michael G. Brant, et al.
SICCA-international Sjogren's syndrome registry: Two year follow-up analyses and elucidation of two keratoconjunctivitis sicca subtypes
2008 · T E Daniels, John S. Greenspan, et al. · Research Portal (King's College London)
Works count: 22
Citation count: 30
H-index: 1
I10-index: 1
Year
Topic
Type